Assessment of differential expression of oncogenes in adenocarcinoma of stomach with fluorescent labeling and simultaneous amplification of gene transcripts

Ferlay J. Globocan 2000: Cancer incidence, mortality, and prevalence worldwide. Lyon: IARC Press; 2001: 1 CD-ROM.Search in Google Scholar

Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64: 31-49.10.1111/apm.1965.64.1.31Search in Google Scholar

Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression. Gastric Cancer 2004; 72: 61-77.10.1007/s10120-004-0277-4Search in Google Scholar

Kufe DW, Holland JF, Frei E, Abramson DH, Dang CT, DeAngelis LM, et al. Cancer medicine 6. Hamilton, Ont.: BC Decker; 2003.Search in Google Scholar

Barletta C, Scillato F, Sega FM, Mannella E. Genetic alteration in gastrointestinal cancer. A molecular and cytogenetic study. Anticancer Res 1993; 136A: 2325-9.Search in Google Scholar

Tahara E. Genetic pathways of two types of gastric cancer. IARC Sci Publ 2004; 157: 327-49.Search in Google Scholar

Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling. Science 2007; 316(5827): 1039-43.10.1126/science.1141478Search in Google Scholar

Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, Archibald H, et al. Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752. Proc Natl Acad Sci USA 2006; 103(7): 2316-21.10.1073/pnas.0508776103Search in Google Scholar

Uen YH, Lin SR, Wu CH, Hsieh JS, Lu CY, Yu FJ, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma. Clin Chim Acta 2006; 367(1-2): 55-61.10.1016/j.cca.2005.11.013Search in Google Scholar

Corso S, Comoglio PM, Giordano S. Cancer therapy: can the challenge be MET? Trends Mol Med 2005; 11(6): 84-92.10.1016/j.molmed.2005.04.005Search in Google Scholar

Felsher DW. Cancer revoked: oncogenes as therapeutic targets. Nat Rev Cancer 2003; 3(5): 375-80.10.1038/nrc1070Search in Google Scholar

Kataoka H, Joh T, Kasugai K, Okayama N, Moriyama A, Asai K, et al. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa. Life Sci 1998; 63(7): 553-64.10.1016/S0024-3205(98)00306-3Search in Google Scholar

Bachmair F, Huber C, Daxenbichler G. Quanititation of gene expression by means of HPLC analysis of RT-PCR products. Clin Chim Acta 1999; 279(1-2): 25-34.10.1016/S0009-8981(98)00162-4Search in Google Scholar

Huber CG. Micropellicular stationary phases for high-performance liquid chromatography of double-stranded DNA. J Chromatogr A 1998; 806: 3-30.10.1016/S0021-9673(97)01124-2Search in Google Scholar

Heideman DA, Snijders PJ, Bloemena E, Meijer CJ, Offerhaus GJ, Meuwissen SG, et al. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma. J Pathol 2001; 194(4): 428-35.10.1002/path.934Search in Google Scholar

Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas. Cancer 1999; 85(9): 1894-902.10.1002/(SICI)1097-0142(19990501)85:9<1894::AID-CNCR3>3.0.CO;2-JSearch in Google Scholar

Rasola A, Fassetta M, De Bacco F, D'Alessandro L, Gramaglia D, Di Renzo MF, et al. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth. Oncogene 2007; 26(7): 1078-87.10.1038/sj.onc.1209859Search in Google Scholar

Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, et al. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells. Mol Cell Biol 2002; 22(8): 2586-97.10.1128/MCB.22.8.2586-2597.2002Search in Google Scholar

Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, et al. Identification of cripto-1 as a novel serologic marker for breast and colon cancer. Clin Cancer Res 2006; 12(17): 5158-64.10.1158/1078-0432.CCR-06-0274Search in Google Scholar

Hamada S, Watanabe K, Hirota M, Bianco C, Strizzi L, Mancino M, et al. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1. Biochem Biophys Res Commun 2007; 355(1): 240-4.10.1016/j.bbrc.2007.01.143Search in Google Scholar

Minchiotti G. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology. Oncogene 2005; 24(37): 5668-75.10.1038/sj.onc.1208917Search in Google Scholar

Haruma K, Ito M, Kohmoto K, Kamada T, Kitada Y, Yasui W, et al. Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: association with Helicobacter pylori infection. Int J Mol Med 2000; 5(2): 185-90.10.3892/ijmm.5.2.185Search in Google Scholar

Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995; 86(7): 617-21.10.1111/j.1349-7006.1995.tb02442.xSearch in Google Scholar

Tenderenda M. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes. J Exp Clin Cancer Res 2005; 24(3): 405-14.Search in Google Scholar

Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005; 8(2): 86-94.10.1007/s10120-005-0320-0Search in Google Scholar

Yu J, Miehlke S, Ebert MP, Szokodi D, Wehvnignh B, Malfertheiner P, et al. Expression of cyclin genes in human gastric cancer and in first degree relatives. Chin Med J (Engl) 2002; 115(5): 710-5.Search in Google Scholar

Breuleux M. Role of heregulin in human cancer. Cell Mol Life Sci 2007; 64(18): 2358-77.10.1007/s00018-007-7120-017530167Search in Google Scholar

Kobayashi M, Iwamatsu A, Shinohara-Kanda A, Ihara S, Fukui Y. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas. Oncogene 2003; 22(9): 1294-301.10.1038/sj.onc.120625612618754Search in Google Scholar

Slesak B, Harlozinska A, Porebska I, Bojarowski T, Lapinska J, Rzeszutko M, et al. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis. Anticancer Res 1998; 18(4A): 2727-32.Search in Google Scholar